DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 01 · Volume 48 · January 2015 DOI: 10.1055/s-004-28360

Erratum

  • e1
    Gahr, M.; Zeiss, R.; Lang, D.; Connemann, B. J.; Hiemke, C.; Freudenmann, R. W.; Schönfeldt-Lecuona, C.:

    Risk of Bleeding Related to Selective and Non-selective Serotonergic Antidepressants: A Case/Non-case Approach Using Data from Two Pharmacovigilance Databases

    • Review

  • 1
    La Torre, A.; Giupponi, G.; Duffy, D.; Conca, A.; Catanzariti, D.:

    Sexual Dysfunction Related to Drugs: A Critical Review. Part IV: Cardiovascular Drugs

    • Original Paper

  • 7
    Soyka, M.; Fischer, W.:

    No Evidence for Development of Tolerance after Repeated Use of Propofol for Electroconvulsive Therapy

  • 11
    Mustafa, F. A.; Burke, J. G.; Abukmeil, S. S.; Scanlon, J. J.; Cox, M.:

    “Schizophrenia past Clozapine”: Reasons for Clozapine Discontinuation, Mortality, and Alternative Antipsychotic Prescribing

  • 15
    Schjerning, O.; Lykkegaard, S.; Damkier, P.; Nielsen, J.:

    Possible Drug-drug Interaction between Pregabalin and Clozapine in Patients with Schizophrenia: Clinical Perspectives

  • 19
    Gahr, M.; Zeiss, R.; Lang, D.; Connemann, B. J.; Hiemke, C.; Freudenmann, R. W.; Schönfeldt-Lecuona, C.:

    Risk of Bleeding Related to Selective and Non-selective Serotonergic Antidepressants: A Case/Non-case Approach Using Data from Two Pharmacovigilance Databases

  • 25
    Lai, C.-L.; Chan, H.-Y.; Pan, Y.-J.; Chen, C.-H.:

    The Effectiveness of a Computer Reminder System for Laboratory Monitoring of Metabolic Syndrome in Schizophrenic Outpatients Using Second-generation Antipsychotics

  • 30
    Kishi, T.; Iwata, N.:

    Efficacy and Tolerability of Histamine-2 Receptor Antagonist Adjunction of Antipsychotic Treatment in Schizophrenia: A Meta-analysis of Randomized Placebo-controlled Trials

    Supporting Information (PDF)

    • Letter

  • 37
    Gronau, W.; Paslakis, G.; Lederbogen, F.; Weber-Hamann, B.; Gilles, M.; Schilling, C.; Deuschle, M.:

    Increased Platelet Count after Treatment with Venlafaxine or Mirtazapine in Depressed Patients